Viridian Therapeutics Stock Guidance | NASDAQ:VRDN | Benzinga

Viridian Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
Viridian Therapeutics Inc (VRDN) does not provide guidance data

FAQ

What is the most recent guidance for Viridian Therapeutics (VRDN)?

There have been no specific sales or earnings guidance reported for Viridian Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

IDEAYA Biosciences Inc

NASDAQ:IDYA

$33.51

0.42%

Ultragenyx Pharmaceutical Inc

NASDAQ:RARE

$34.88

-3.74%

Centessa Pharmaceuticals PLC

NASDAQ:CNTA

$25.76

-1.51%

Arcutis Biotherapeutics Inc

NASDAQ:ARQT

$28.69

-0.90%

Xenon Pharmaceuticals Inc

NASDAQ:XENE

$43.74

-0.30%

Kiniksa Pharmaceuticals International PLC

NASDAQ:KNSA

$41.55

-0.14%

Olema Pharmaceuticals inc

NASDAQ:OLMA

$35.63

-1.74%

Dyne Therapeutics Inc

NASDAQ:DYN

$19.60

0.05%

Comments

Viridian Therapeutics Stock Guidance

Viridian Therapeutics Stock Guidance | NASDAQ:VRDN | Benzinga

FAQ

What is the most recent guidance for Viridian Therapeutics (VRDN)?

People Also Watch